Skip to main content
. 2019 Nov 12;7(12):3979–3985. doi: 10.1002/fsn3.1259

Figure 6.

Figure 6

In vivo effect of astaxanthin (ATX) on erythrocyte aldose reductase (AR) activity in control (C) P. ob. (n = 4), in diabetic (D) P. ob. with hypercaloric diet during 7 months (n = 4) and in diabetic P. ob. fed with astaxanthin (ATX) the last week of the 7th month (n = 4). (*): designates statistical significance in comparison D P. ob. with P. ob. fed with ATX; (p < .05)